| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.5M | +563.1% |
| Cost of Revenue | $6.4M | +77.6% |
| R&D Expense | $14.3M | -44.1% |
| SG&A Expense | $30.9M | -24.6% |
| Operating Income | -$68.8M | +24.3% |
| Interest Expense | $589K | -53.7% |
| Pre-tax Income | -$79.3M | +23.2% |
| Net Income | -$64.2M | +27.9% |
| EPS (Basic) | -$9.16 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.6M | -50.6% |
| Accounts Receivable | $61K | +258.8% |
| Inventory | $278K | +150.5% |
| Current Assets | $24.5M | -44.2% |
| Total Assets | $33.1M | -38.6% |
| Current Liabilities | $54.2M | +31.5% |
| Total Liabilities | $57.1M | +32.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.0M | +26.7% |
| Capital Expenditures | $242K | -84.3% |
| Investing Cash Flow | $758K | +116.0% |
| Financing Cash Flow | $31.2M | -18.4% |
| Free Cash Flow | -$52.3M | +27.9% |
| -816.0% |
| EPS (Diluted) | -$9.16 | +39.1% |
| Stockholders' Equity |
| -$53.8M |
| -456.0% |